Nova Patents
MA44726A

Administration of a bispecific construct binding to cd33 and cd3 for use in a method for the treatment of myeloid leukemia

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

23 members in 18 offices

This recordMember, by publication datePriority claim8 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
201662324451United States of AmericaP
201662324451United States of AmericaP
201662324451P–––
US201662324451P–––

Members23

Family members, oldest first
DocumentOfficeKind
CA3019740A1CanadaA1
WO2017182427A1World Intellectual Property Organization (WIPO)A1
TW201741339ATaiwan Province of ChinaA
AU2017253621A1AustraliaA1
SG11201808656SASingaporeA
IL262423AIsraelA
IL262423D0IsraelD0
BR112018070946A2BrazilA2
EP3445784A1European Patent Office (EPO)A1
MA44726AThis recordMoroccoA
EA201892367A1Eurasian Patent Organization (EAPO)A1
US2019127465A1United States of AmericaA1
MX2018012717AMexicoA
JP2019514871AJapanA
ZA201806514BSouth AfricaB
PH12018502230A1PhilippinesA1
US11053318B2United States of AmericaB2
JOP20170091B1JordanB1
EA038736B1Eurasian Patent Organization (EAPO)B1
UA124732C2UkraineC2
TWI752952BTaiwan Province of ChinaB
EP3445784B1European Patent Office (EPO)B1
MY194062AMalaysiaA